Health & Fitness
Health and Fitness
Health and Fitness
Thu, July 14, 2011
Wed, July 13, 2011 Incyte Reports Second Quarter 2011 Financial Results and Provides Update on Key Clinical Programs on July 28
WILMINGTON, Del.--([ BUSINESS WIRE ])--Incyte Corporation (Nasdaq: INCY) announced today that it has scheduled its second quarter 2011 financial results conference call for 8:30 a.m. ET on Thursday, July 28, 2011. The schedules for the press release and conference call are as follows:
| -- Q2 2011 Press Release: | July 28, 2011 at 7:00 a.m. ET | |||
| -- Q2 2011 Conference Call: | July 28, 2011 at 8:30 a.m. ET | |||
| -- Domestic Dial In Number: | 877-407-8037 | |||
| -- International Dial In Number: | 201-689-8037 | |||
| -- Conference ID # | 375487 | |||
If you are unable to participate, a replay of the conference call will be available for thirty days. The replay dial-in number for the U.S. is 877-660-6853 and dial-in number for international callers is 201-612-7415. To access the replay you will need the conference account number 278 and the ID number 375487.
The conference call will also be webcast live and can be accessed at [ www.incyte.com ] under Investor Relations, Events and Webcasts.
About Incyte
Incyte Corporation is a Wilmington, Delaware-based drug discovery and development company focused on developing proprietary small molecule drugs for oncology and inflammation. For additional information on Incyte, visit the Company's web site at [ www.incyte.com ].
